Real-world flash glucose monitoring in Brazil: can sensors make a difference in diabetes management in developing countries?

Blood glucose monitoring frequency Continuous glucose monitoring Flash glucose monitoring Glycemic measures Real-world data

Journal

Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958

Informations de publication

Date de publication:
2020
Historique:
received: 26 10 2019
accepted: 27 12 2019
entrez: 11 1 2020
pubmed: 11 1 2020
medline: 11 1 2020
Statut: epublish

Résumé

New technologies are changing diabetes treatment and contributing better outcomes in developed countries. To our knowledge, no previous studies have investigated the comparative effect of sensor-based monitoring on glycemic markers in developing countries like Brazil. The present study aims to evaluate the use of intermittent Continuous Glucose Measurements (iCGM) in a developing country, Brazil, regarding (i) frequency of glucose scans, (ii) its association with glycemic markers and (iii) comparison with these findings to those observed in global population data. Glucose results were de-identified and uploaded to a dedicated database when Freestyle Libre™ readers were connected to an internet-ready computer. Data between September 2014 and Dec 2018, comprising 688,640 readers and 7,329,052 sensors worldwide, were analysed (including 17,691 readers and 147,166 sensors from Brazil). Scan rate per reader was determined and each reader was sorted into 20 equally-sized rank ordered groups, categorised by scan frequency. Glucose parameters were calculated for each group, including estimated A1c, time above, below and within range identified as 70-180 mg/dL. In Brazil, reader users performed an average of 14 scans per day, while around the world, reader users performed an average of 12 scans per day (p < 0.01). In Brazil dataset, those in the lowest and in the highest groups scanned on average 3.6 and 43.1 times per day had an estimated A1c of 7.56% (59 mmol/mol) and 6.71% (50 mmol/mol), respectively (p < 0.01). Worldwide, the lowest group and the highest groups scanned 3.4 times/day and 37.8 times/day and had an eA1c of 8.14% (65 mmol/mol) and 6.70% (50 mmol/mol), respectively (p < 0.01). For the scan groups in both populations, the time spent above 180 mg/dL decreased as the scan frequency increased. In both Brazil and around the world, as scan frequency increased, time in range (TIR) increased. In Brazil, TIR increased from 14.15 to 16.62 h/day (p < 0.01). Worldwide, TIR increased from 12.06 to 16.97 h/day (p < 0.01). We conclude that Brazilian users have a high frequency of scans, more frequent than global data. Similarly to the world findings, increased scan frequency is associated with better glycemic control.

Sections du résumé

BACKGROUND BACKGROUND
New technologies are changing diabetes treatment and contributing better outcomes in developed countries. To our knowledge, no previous studies have investigated the comparative effect of sensor-based monitoring on glycemic markers in developing countries like Brazil. The present study aims to evaluate the use of intermittent Continuous Glucose Measurements (iCGM) in a developing country, Brazil, regarding (i) frequency of glucose scans, (ii) its association with glycemic markers and (iii) comparison with these findings to those observed in global population data.
METHODS METHODS
Glucose results were de-identified and uploaded to a dedicated database when Freestyle Libre™ readers were connected to an internet-ready computer. Data between September 2014 and Dec 2018, comprising 688,640 readers and 7,329,052 sensors worldwide, were analysed (including 17,691 readers and 147,166 sensors from Brazil). Scan rate per reader was determined and each reader was sorted into 20 equally-sized rank ordered groups, categorised by scan frequency. Glucose parameters were calculated for each group, including estimated A1c, time above, below and within range identified as 70-180 mg/dL.
RESULTS RESULTS
In Brazil, reader users performed an average of 14 scans per day, while around the world, reader users performed an average of 12 scans per day (p < 0.01). In Brazil dataset, those in the lowest and in the highest groups scanned on average 3.6 and 43.1 times per day had an estimated A1c of 7.56% (59 mmol/mol) and 6.71% (50 mmol/mol), respectively (p < 0.01). Worldwide, the lowest group and the highest groups scanned 3.4 times/day and 37.8 times/day and had an eA1c of 8.14% (65 mmol/mol) and 6.70% (50 mmol/mol), respectively (p < 0.01). For the scan groups in both populations, the time spent above 180 mg/dL decreased as the scan frequency increased. In both Brazil and around the world, as scan frequency increased, time in range (TIR) increased. In Brazil, TIR increased from 14.15 to 16.62 h/day (p < 0.01). Worldwide, TIR increased from 12.06 to 16.97 h/day (p < 0.01).
CONCLUSIONS CONCLUSIONS
We conclude that Brazilian users have a high frequency of scans, more frequent than global data. Similarly to the world findings, increased scan frequency is associated with better glycemic control.

Identifiants

pubmed: 31921360
doi: 10.1186/s13098-019-0513-z
pii: 513
pmc: PMC6947827
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsYR, DEB, YX, and TD are employees of Abbott Diabetes Care.

Références

Diabetes Care. 2008 Aug;31(8):1473-8
pubmed: 18540046
Diabetes Care. 2017 Jan;40(1):155-157
pubmed: 27872155
Lancet. 2016 Nov 5;388(10057):2254-2263
pubmed: 27634581
Diabetes Care. 2013 Jul;36(7):2009-14
pubmed: 23378621
Diabetes Res Clin Pract. 2018 Mar;137:37-46
pubmed: 29278709
Diabetes Care. 2018 Jun;41(6):e92-e94
pubmed: 29784704
Diabetes Care. 2019 Jan;42(Suppl 1):S71-S80
pubmed: 30559233
Diabetes Care. 2017 Dec;40(12):1631-1640
pubmed: 29162583
BMJ Open Diabetes Res Care. 2019 Mar 25;7(1):e000611
pubmed: 31114698
Diabetes Care. 2018 Nov;41(11):2370-2376
pubmed: 30201847
Diabetologia. 2018 Mar;61(3):539-550
pubmed: 29273897
Diabetes Care. 2018 Jan;41(Suppl 1):S55-S64
pubmed: 29222377
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
Diabetes Care. 1998 Sep;21(9):1414-31
pubmed: 9727886
Diabetes Care. 2016 Apr;39(4):603-10
pubmed: 26681721
Ann Intern Med. 2017 Jul 18;167(2):95-102
pubmed: 28605777
J Diabetes Sci Technol. 2008 Sep;2(5):919-21
pubmed: 19885279
Diabetes Care. 2019 Mar;42(3):400-405
pubmed: 30352896

Auteurs

Luis Eduardo P Calliari (LEP)

1Santa Casa de Sao Paulo School of Medical Sciences, São Paulo, Brazil.

Marcio Krakauer (M)

Centro de Pesquisa Clínica do Grupo Leforte, São Paulo, Brazil.

Andre Gustavo Daher Vianna (AGD)

Centro de Diabetes Curitiba, Curitiba, Brazil.

Yashesvini Ram (Y)

Abbott Diabetes Care, Alameda, CA USA.

Douglas Eugenio Barbieri (DE)

Abbott Diabetes Care, Alameda, CA USA.

Yongjin Xu (Y)

Abbott Diabetes Care, Alameda, CA USA.

Timothy C Dunn (TC)

Abbott Diabetes Care, Alameda, CA USA.

Classifications MeSH